OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Immunology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Editorial Board	196
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer	163
Exploiting antifungal immunity in the clinical context	95
Differential immune responses behind different celiac disease manifestations	83
Cellular stress and macrophage activation	70
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity	62
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells	62
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi	61
Pyroptosis modulation by bacterial effector proteins	58
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity	56
Resolving inflammatory links between myocardial infarction and vascular dementia	53
Aging of lymphoid stromal architecture impacts immune responses	51
Editorial Board	49
Local and Cell-intrinsic complement: The new player in cancer progression	47
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges	45
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)	45
Microbial metabolites and immunotherapy: Basic rationale and clinical indications	45
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity	43
Immunity to pathogenic fungi in the eye	43
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?	41
The noncanonical inflammasome-induced pyroptosis and septic shock	40
Pyroptosis and the cellular consequences of gasdermin pores	38
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease	38
Pyroptosis: A road to next-generation cancer immunotherapy	37
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity	37

Interplay between the complement system and other immune pathways in the tumor microenvironment	37
Western diet influences on microbiome and carcinogenesis	34
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment	34
Introduction to the special issue: Neutrophils in the tumor microenvironment	32
Immunity to fungi: Editorial overview	32
Cellular and molecular diversity in spondyloarthritis	31
The evolving biology of cross-presentation	29
The paradox of aging: Aging-related shifts in T cell function and metabolism	29
Neuroimmune interactions between itch neurons and skin microbes	28
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets	28
Autoimmune diabetes and targets for immunomodulation	27
Adaptive NK cell response to human cytomegalovirus: Facts and open issues	27
TREM2: A new player in the tumor microenvironment	26
Specialized pro-resolving mediators as modulators of immune responses	26
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases	26
Recent developments in C3-targeted complement therapeutics	25
Thymus aging and immune reconstitution, progresses and challenges	24
Antigen discovery for the development of cancer immunotherapy	24
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy	23
Sialic acid and Siglec receptors in tumor immunity and immunotherapy	23
The dual role of neutrophils in cancer	23
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic	22
T cell control of SARS-CoV-2: When, which, and where?	22
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases	22
Introduction to the Special Issue: Nutrition, microbiota and immunity	22
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination	22
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs	22
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity	21
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy	21
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?	21
Targeting the tissue-complosome for curbing inflammatory disease	21
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders	20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity	20
Publisher's note: Welcome Prof. Guido Kroemer	20
T cell fate decisions during memory cell generation with aging	20
Editorial Board	19
Better safe than sorry: Naive T-cell dynamics in healthy ageing	19
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice	19